Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2005-11-3
pubmed:abstractText
The ability of Frzb/secreted Frizzled-related protein 3 (sFRP3) to inhibit Wnt signaling and the localization of Frzb/sFRP3 on chromosome 2q to a region frequently deleted in cancers have led some investigators to hypothesize that Frzb/sFRP3 is a tumor suppressor gene. Here, we examined the biological effects of Frzb/sFRP3 on an androgen-independent prostate cancer cell model. We showed that expression of Frzb/sFRP3 in PC-3 cells resulted in decreased colony formation in soft agar and a dramatic inhibition of tumor growth in a xenograft mouse model. When cellular morphology was examined, PC-3 cells expressing Frzb/sFRP3 exhibited an increase in cell-cell contact formation accompanied by a pronounced induction of epithelial markers E-cadherin and keratin-8 and down-regulation of mesenchymal markers N-cadherin, fibronectin, and vimentin. This phenomenon suggested a reversal of epithelial-to-mesenchymal transition and a less invasive phenotype. Indeed, further in vitro studies with a Matrigel assay showed that Frzb/sFRP3 decreased the invasive capacity of PC-3 cells. These changes in the biology of PC-3 cells are associated with a decrease in the expression and activities of both matrix metalloproteinase (MMP)-2 and MMP-9 as well as decreases in AKT activation, cytosolic beta-catenin levels, T-cell factor transcription activity, and expression of Slug and Twist. In addition, transfection of PC-3 with a dominant-negative low-density lipoprotein receptor-related protein 5 (DN-LRP5) coreceptor showed similar biological effects as Frzb/sFRP3 transfection. Together, these data suggest that Frzb/sFRP3 and DN-LRP5 exhibit antitumor activity through the reversal of epithelial-to-mesenchymal transition and inhibition of MMP activities in a subset of prostate cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins, http://linkedlifedata.com/resource/pubmed/chemical/Keratins, http://linkedlifedata.com/resource/pubmed/chemical/LDL-Receptor Related Proteins, http://linkedlifedata.com/resource/pubmed/chemical/LRP5 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Low Density Lipoprotein..., http://linkedlifedata.com/resource/pubmed/chemical/Lrp5 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Wnt Proteins, http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin, http://linkedlifedata.com/resource/pubmed/chemical/frizzled related protein-3
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9762-70
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16266997-Animals, pubmed-meshheading:16266997-Cadherins, pubmed-meshheading:16266997-Cattle, pubmed-meshheading:16266997-Cell Adhesion, pubmed-meshheading:16266997-Cell Growth Processes, pubmed-meshheading:16266997-Cell Line, Tumor, pubmed-meshheading:16266997-Humans, pubmed-meshheading:16266997-Keratins, pubmed-meshheading:16266997-LDL-Receptor Related Proteins, pubmed-meshheading:16266997-Low Density Lipoprotein Receptor-Related Protein-5, pubmed-meshheading:16266997-Male, pubmed-meshheading:16266997-Matrix Metalloproteinase 2, pubmed-meshheading:16266997-Matrix Metalloproteinase 9, pubmed-meshheading:16266997-Mice, pubmed-meshheading:16266997-Mice, Nude, pubmed-meshheading:16266997-Neoplasm Invasiveness, pubmed-meshheading:16266997-Neoplasms, Hormone-Dependent, pubmed-meshheading:16266997-Prostatic Neoplasms, pubmed-meshheading:16266997-Proteins, pubmed-meshheading:16266997-Signal Transduction, pubmed-meshheading:16266997-Transfection, pubmed-meshheading:16266997-Wnt Proteins, pubmed-meshheading:16266997-Xenograft Model Antitumor Assays, pubmed-meshheading:16266997-beta Catenin
pubmed:year
2005
pubmed:articleTitle
Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
pubmed:affiliation
Department of Urology, University of California, Irvine, Orange, California 92868, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't